Hormone replacement therapy

Hormone replacement therapy (HRT) is a medical treatment that supplements deficient hormones in individuals experiencing menopause, andropause, or other hormonal imbalances. Most US insurance companies define HRT as a covered benefit for medically necessary indications like menopausal symptoms or hypogonadism, according to Aetna and UnitedHealthcare policies.

Insurance carriers require documented lab results, such as estradiol levels under 20 pg/mL or testosterone under 300 ng/dL, before approving coverage for HRT prescriptions, as determined by Your Insurance Info. Many plans exclude coverage for compounded bioidentical HRT formulations but include FDA-approved versions like Premarin or AndroGel.

US insurance providers frequently deny claims for HRT prescribed solely for anti-aging or non-medically indicated uses. Plans often require prior authorization forms completed by board-certified endocrinologists or gynecologists before covering injectable therapies.

Medicare covers estrogen therapy only when patients meet strict diagnosis criteria and typically does not cover testosterone in women. Out-of-pocket costs for HRT range from $10 to $85 per month with insurance copays, while uninsured patients can pay over $100 monthly for branded drugs.

Some insurers–such as Blue Cross Blue Shield–impose annual quantity limits on transdermal patches (e.g. 8 patches per month). Prescription drug formularies published by Cigna list covered HRT medications, including Vivelle-Dot and Estrace, but exclude unapproved herbal or over-the-counter hormone products.